- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05253651
En undersøgelse af Tucatinib med Trastuzumab og mFOLFOX6 versus standardbehandling i førstelinje HER2+ metastatisk kolorektal cancer (MOUNTAINEER-03)
Et åbent randomiseret fase 3-studie af Tucatinib i kombination med Trastuzumab og mFOLFOX6 versus mFOLFOX6 givet med eller uden enten Cetuximab eller Bevacizumab som førstelinjebehandling til forsøgspersoner med HER2+ metastatisk kolorektal cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease.
Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable).
Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either:
- mFOLFOX6 alone,
- mFOLFOX6 with bevacizumab, or
- mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
-
Buenos Aires, Argentina, 1426
- Instituto Medico Especializado Alexander Fleming
-
CABA, Argentina, 1280
- Hospital Britanico de Buenos Aires
-
Córdoba, Argentina, X5001 HWE
- IONC Instituto Oncologico de Cordoba Fundacion Richardet Longo
-
Córdoba, Argentina
- CEMAIC - Centro Medico Privado
-
-
Buenos Aires
-
Pergamino, Buenos Aires, Argentina, 2700
- Centro de Investigacion Pergamino SA
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, S2000DEJ
- Instituto Medico de la Fundacion Estudios Clinicos
-
-
-
-
New South Wales
-
Camperdown, New South Wales, Australien, 2050
- Chris O'Brien Lifehouse
-
-
Victoria
-
Fitzroy, Victoria, Australien, 3065
- St Vincent's Hospital
-
-
-
-
-
Anderlecht, Belgien, 1070
- Institut Jules Bordet
-
Brussels, Belgien, 1200
- Cliniques Universitaires Saint-Luc
-
Edegem, Belgien, 2650
- UZA
-
Turnhout, Belgien, 2300
- Maag-,Darm- en Leverziekten AZ Turnhout
-
Turnhout, Belgien, 2300
- Oncologisch Dagziekenhuis AZ Turnhout Campus Sint-Elisabeth
-
-
-
-
-
São Paulo, Brasilien, 01245-000
- ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira.
-
-
Paraná
-
Curitiba, Paraná, Brasilien, 80810-050
- CIONC-Centro Integrado de Oncologia de Curitiba
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasilien, 91350-200
- Centro Integrado de Pesquisa em Oncologia CIPO-GHC / Hospital Nossa Senhora da Conceicao
-
-
Rio de Janeiro
-
Barra da Tijuca, Rio de Janeiro, Brasilien, 22.775-001
- Instituto De Educação, Pesquisa e Gestão em Saúde - Instituto Américas
-
Rio de Janeiro, Rio de Janeiro, Brasilien, 22775-001
- Institute de Educacao, Pesquisa e Gestao em Saude - Instituto COI
-
Rio de Janeiro, Rio de Janeiro, Brasilien, 22793-080
- Institute de Educacao, Pesquisa e Gestao em Saude - Instituto COI
-
-
São Paulo
-
Barretos, São Paulo, Brasilien, 14784-400
- Hospital de Cancer de Barretos/Fundacao Pio XII
-
Jaú, São Paulo, Brasilien, 17210-120
- Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho
-
Santo André, São Paulo, Brasilien, 09060-650
- CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia.
-
São José do Rio Preto, São Paulo, Brasilien, CEP 15090-000
- Fundação Faculdade Regional de Medicina de São José do Rio Preto
-
-
-
-
Ontario
-
Ottawa, Ontario, Canada, K1H 8L6
- The Ottawa Hospital Cancer Centre
-
Toronto, Ontario, Canada, M5G 1X5
- Mount Sinai Hospital
-
Toronto, Ontario, Canada, M4N 3M5
- Sunnybrook Research Institute
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1E2
- Jewish General Hospital
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7N 4H4
- Saskatoon Cancer Centre
-
-
-
-
-
Concepción, Chile
- Biocenter
-
Santiago, Chile
- Centro de estudios clinicos SAGA
-
-
Valparaiso
-
Viña del Mar, Valparaiso, Chile
- Oncocentro Apys
-
-
-
-
-
Leeds, Det Forenede Kongerige, LS97TF
- Leeds Teaching Hospitals NHS Trust, st James's Institute of Oncology
-
London, Det Forenede Kongerige, W12 0NN
- Imperial College Healthcare NHS Trust
-
London, Det Forenede Kongerige, SW3 6JJ
- The Royal Marsden Hospital - Chelsea Site
-
Manchester, Det Forenede Kongerige, M20 4BX
- The Christie NHS Foundation Trust
-
-
Chelsea
-
Newcastle upon Tyne, Chelsea, Det Forenede Kongerige, NE7 7DN
- The Newcastle upon Tyne Hospitals NHS Foundation Trust
-
-
England
-
Cambridge, England, Det Forenede Kongerige, CB2 0QQ
- Cambridge University Hospitals NHS Foundation Trust, Oncology Centre
-
-
Surrey
-
Sutton, Surrey, Det Forenede Kongerige, SM2 5PT
- The Royal Marsden Hospital
-
-
-
-
Arizona
-
Glendale, Arizona, Forenede Stater, 85304
- Palo Verde Hematology Oncology
-
Phoenix, Arizona, Forenede Stater, 85054
- Mayo Clinic Hospital
-
Phoenix, Arizona, Forenede Stater, 85054
- Mayo Clinic Building - Phoenix
-
Scottsdale, Arizona, Forenede Stater, 85259
- Mayo Clinic
-
-
California
-
Anaheim, California, Forenede Stater, 92801
- Los Angeles Cancer Network - Anaheim
-
Anaheim, California, Forenede Stater, 92806
- Kaiser Permanente Anaheim Kraemer Medical Offices
-
Baldwin Park, California, Forenede Stater, 91706
- Kaiser Permanente Baldwin Park Medical Center
-
Bellflower, California, Forenede Stater, 90706
- Kaiser Permanente Bellflower Medical Offices
-
Fontana, California, Forenede Stater, 92335
- Kaiser Permanente Fontana Medical Center
-
Fountain Valley, California, Forenede Stater, 92708
- Los Angeles Cancer Network - Fountain Vally
-
Glendale, California, Forenede Stater, 91204
- Los Angeles Hematology Oncology Medical Group
-
Glendale, California, Forenede Stater, 91206
- Los Angeles Hematology Oncology Medical Group
-
Glendale, California, Forenede Stater, 91204
- Los Angeles Cancer Network - Corporate Office
-
Harbor City, California, Forenede Stater, 90710
- Kaiser Permanente South Bay Medical center
-
Irvine, California, Forenede Stater, 92618
- Kaiser Permanente Alton/Sand Canyon Medical Offices
-
Los Angeles, California, Forenede Stater, 90017
- Los Angeles Hematology Oncology Medical Group
-
Los Angeles, California, Forenede Stater, 90033
- USC/Norris Comprehensive Cancer Center
-
Los Angeles, California, Forenede Stater, 90033
- Keck Hospital of USC
-
Los Angeles, California, Forenede Stater, 90033
- Los Angeles General Medical Center
-
Los Angeles, California, Forenede Stater, 90034
- Kaiser Permanente West Los Angeles Medical Center
-
Los Angeles, California, Forenede Stater, 90020
- USC Norris Koreatown - Medical Oncology
-
Los Angeles, California, Forenede Stater, 90027
- Kaiser Permanente Los Angeles Medical Offices
-
Newport Beach, California, Forenede Stater, 92663
- USC Norris Oncology/Hematology - Newport Beach
-
Ontario, California, Forenede Stater, 91761
- Kaiser Permanente Ontario Medical Center
-
Panorama City, California, Forenede Stater, 91402
- Kaiser Permanente Panorama City Medical Center
-
Pasadena, California, Forenede Stater, 91105
- Keck Medical Center of USC Pasadena
-
Pasadena, California, Forenede Stater, 91105
- Los Angeles Hematology Oncology Medical Group
-
Riverside, California, Forenede Stater, 92505
- Kaiser Permanente Riverside Medical Center
-
San Diego, California, Forenede Stater, 92108
- Kaiser Permanente San Diego Mission Road (Regulatory and Lab Supplies)
-
San Diego, California, Forenede Stater, 92120
- Kaiser Permanente Zion Medical Center
-
San Marcos, California, Forenede Stater, 92078
- Kaiser Permanente San Marcos Medical Offices
-
Van Nuys, California, Forenede Stater, 91405
- Los Angeles Hematology Oncology Medical Group
-
Woodland Hills, California, Forenede Stater, 91367
- Kaiser Permanente Woodland Hills Medical Center
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80012
- Rocky Mountain Cancer Centers, LLP
-
Boulder, Colorado, Forenede Stater, 80303
- Rocky Mountain Cancer Centers, LLP
-
Colorado Springs, Colorado, Forenede Stater, 80907
- Rocky Mountain Cancer Centers, LLP
-
Denver, Colorado, Forenede Stater, 80218
- Rocky Mountain Cancer Centers, LLP
-
Denver, Colorado, Forenede Stater, 80220
- Rocky Mountain Cancer Centers, LLP
-
Lakewood, Colorado, Forenede Stater, 80228
- Rocky Mountain Cancer Centers, LLP
-
Littleton, Colorado, Forenede Stater, 80120
- Rocky Mountain Cancer Centers, LLP
-
Lone Tree, Colorado, Forenede Stater, 80124
- Rocky Mountain Cancer Centers, LLP
-
Longmont, Colorado, Forenede Stater, 80504
- Rocky Mountain Cancer Centers, LLP
-
Pueblo, Colorado, Forenede Stater, 81003
- Rocky Mountain Cancer Centers, LLP
-
Thornton, Colorado, Forenede Stater, 80260
- Rocky Mountain Cancer Centers, LLP
-
-
Florida
-
Aventura, Florida, Forenede Stater, 33180
- Mount Sinai Medical Center Aventura ER
-
Miami Beach, Florida, Forenede Stater, 33140
- Mount Sinai Medical Center
-
Miami Beach, Florida, Forenede Stater, 33140
- Mount Sinai Braman Comprehensive Cancer Center
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30322
- Emory University Hospital
-
Atlanta, Georgia, Forenede Stater, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Forenede Stater, 30342
- Emory Saint Joseph's Hospital
-
Atlanta, Georgia, Forenede Stater, 30322
- Winship Cancer Institute
-
-
Kansas
-
Merriam, Kansas, Forenede Stater, 66204
- Alliance for Multispecialty Research LLC.
-
-
Kentucky
-
Louisville, Kentucky, Forenede Stater, 40202
- Norton Hospital
-
Louisville, Kentucky, Forenede Stater, 40217
- Norton Cancer Institute, Audubon Hospital Campus
-
Louisville, Kentucky, Forenede Stater, 40241
- Norton Brownsboro Hospital
-
Louisville, Kentucky, Forenede Stater, 40241
- Norton Cancer Institute, Brownsboro Hospital Campus
-
Louisville, Kentucky, Forenede Stater, 40202
- Norton Cancer Institute, Downtown
-
Louisville, Kentucky, Forenede Stater, 40217
- Norton Audubon Hospital
-
Louisville, Kentucky, Forenede Stater, 40202
- Norton Cancer Institute - Downtown
-
-
Minnesota
-
Burnsville, Minnesota, Forenede Stater, 55337
- Minnesota Oncology Hematology, PA
-
Coon Rapids, Minnesota, Forenede Stater, 55433
- Minnesota Oncology Hematology, PA
-
Coon Rapids, Minnesota, Forenede Stater, 55433
- Allina Health Cancer institute
-
Edina, Minnesota, Forenede Stater, 55435
- Minnesota Oncology Hematology, PA
-
Edina, Minnesota, Forenede Stater, 55435
- M Health Fairview Cancer Clinic-Edina
-
Maple Grove, Minnesota, Forenede Stater, 55369
- Minnesota Oncology Hematology, PA
-
Maplewood, Minnesota, Forenede Stater, 55109
- M Health Fairview St. John's Hospital
-
Maplewood, Minnesota, Forenede Stater, 55109
- Minnesota Oncology Hematology, PA
-
Minneapolis, Minnesota, Forenede Stater, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Forenede Stater, 55404
- Allina Health Cancer Institute (Virginia Piper Cancer Institute)
-
Robbinsdale, Minnesota, Forenede Stater, 55422
- North Memorial Health Cancer Center
-
Rochester, Minnesota, Forenede Stater, 55905
- Mayo Clinic Cancer Center Outpatient Pharmacy
-
Saint Louis Park, Minnesota, Forenede Stater, 55426
- Park Nicollet Frauenshuh Cancer Center
-
Saint Louis Park, Minnesota, Forenede Stater, 55416
- Metro Minnesota Community Oncology Research Consortium
-
Saint Louis Park, Minnesota, Forenede Stater, 55426
- Regulatory Location: MMCORC
-
Saint Paul, Minnesota, Forenede Stater, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Forenede Stater, 55102
- Allina Health Cancer Institute-United(VPCI)
-
Waconia, Minnesota, Forenede Stater, 55387
- Minnesota Oncology & Ridgeview Cancer & Infusion Center
-
Woodbury, Minnesota, Forenede Stater, 55125
- Minnesota Oncology Hematology, PA Cornerstone Medical Specialty Center
-
-
New Jersey
-
Basking Ridge, New Jersey, Forenede Stater, 07920
- MSK Basking Ridge
-
Middletown, New Jersey, Forenede Stater, 07748
- MSK Monmouth
-
Montvale, New Jersey, Forenede Stater, 07645
- MSK Bergen
-
-
New York
-
Commack, New York, Forenede Stater, 11725
- MSK Commack
-
Harrison, New York, Forenede Stater, 10604
- MSK Westchester
-
New York, New York, Forenede Stater, 10065
- Memorial Sloan Kettering Cancer Center - Main Campus
-
New York, New York, Forenede Stater, 10022
- Rockefeller Outpatient Pavilion (53rd Street)
-
Uniondale, New York, Forenede Stater, 11553
- MSK Nassau
-
-
North Carolina
-
Durham, North Carolina, Forenede Stater, 27710
- Duke University Medical Center
-
Durham, North Carolina, Forenede Stater, 27710
- Duke University Hospital
-
Durham, North Carolina, Forenede Stater, 27710
- Duke University Medical Center, Duke Cancer Center
-
Pinehurst, North Carolina, Forenede Stater, 28374
- FirstHealth Cancer Center
-
Pinehurst, North Carolina, Forenede Stater, 28374
- FirstHealth Moore Regional Hospital
-
-
Ohio
-
Canton, Ohio, Forenede Stater, 44718
- Gabrail Cancer Center Research
-
-
Oregon
-
Happy Valley, Oregon, Forenede Stater, 97015
- Northwest Cancer Specialists, P.C
-
Portland, Oregon, Forenede Stater, 97213
- Providence Cancer Institute Franz Clinic
-
Portland, Oregon, Forenede Stater, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Forenede Stater, 97227
- Northwest Cancer Specialists, P.C.
-
Portland, Oregon, Forenede Stater, 97225
- Providence St. Vincent Medical Center
-
Portland, Oregon, Forenede Stater, 97225
- Providence Oncology and Hematology Care Clinic - Westside
-
Tigard, Oregon, Forenede Stater, 97223
- Northwest Cancer Specialists, P.C.
-
-
Pennsylvania
-
Beaver, Pennsylvania, Forenede Stater, 15009
- UPMC Hillman Cancer Center - Beaver
-
Butler, Pennsylvania, Forenede Stater, 16001
- UPMC Hillman Cancer Center at Butler Health System
-
Erie, Pennsylvania, Forenede Stater, 16505
- UPMC Hillman Cancer Center Erie
-
Greensburg, Pennsylvania, Forenede Stater, 15601
- UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health
-
Harrisburg, Pennsylvania, Forenede Stater, 17109
- UPMC Hillman Cancer Center - Pinnacle (Community Osteopathic / Medical Sciences Pavillion)
-
Irwin, Pennsylvania, Forenede Stater, 15642
- UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health
-
Mechanicsburg, Pennsylvania, Forenede Stater, 17050
- UPMC Hillman Cancer Center - Pinnacle (Ortenzio)
-
Monroeville, Pennsylvania, Forenede Stater, 15146
- UPMC Hillman Cancer Center - Monroeville
-
Pittsburgh, Pennsylvania, Forenede Stater, 15232
- UPMC Hillman Cancer Center
-
Pittsburgh, Pennsylvania, Forenede Stater, 15237
- UPMC Hillman Cancer Center - Passavant (HOA)
-
Pittsburgh, Pennsylvania, Forenede Stater, 15215
- UPMC Hillman Cancer Center - St Margarets
-
Pittsburgh, Pennsylvania, Forenede Stater, 15243
- St. Clair Cancer Center Medical Oncology
-
-
South Dakota
-
Sioux Falls, South Dakota, Forenede Stater, 57105
- Avera Cancer Institute
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37232
- Henry-Joyce Cancer Clinic
-
-
Texas
-
Arlington, Texas, Forenede Stater, 76012
- Texas Oncology - DFW
-
Arlington, Texas, Forenede Stater, 76014
- Texas Oncology - DFW
-
Bedford, Texas, Forenede Stater, 76022
- Texas Oncology - DFW
-
Dallas, Texas, Forenede Stater, 75246
- Texas Oncology - DFW
-
Dallas, Texas, Forenede Stater, 75231
- Texas Oncology - DFW
-
Dallas, Texas, Forenede Stater, 75203
- Texas Oncology - DFW
-
Dallas, Texas, Forenede Stater, 75230
- Texas Oncology - DFW
-
Dallas, Texas, Forenede Stater, 75237
- Texas Oncology - DFW
-
Fort Worth, Texas, Forenede Stater, 76104
- Texas Oncology - DFW
-
Grapevine, Texas, Forenede Stater, 76051
- Texas Oncology - DFW
-
Houston, Texas, Forenede Stater, 77030
- The University of Texas MD Anderson Cancer Center
-
Plano, Texas, Forenede Stater, 75075
- Texas Oncology - DFW
-
Plano, Texas, Forenede Stater, 75093
- Texas Oncology - DFW
-
-
Virginia
-
Blacksburg, Virginia, Forenede Stater, 24060
- Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care
-
Low Moor, Virginia, Forenede Stater, 24457
- Oncology & Hematology Associates of Southwest Virginia
-
Roanoke, Virginia, Forenede Stater, 24014
- Oncology & Hematology Associates of Southwest Virginia Inc dba Blue Ridge Cancer Care
-
Salem, Virginia, Forenede Stater, 24153
- Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care
-
Wytheville, Virginia, Forenede Stater, 24382
- Oncology & Hematology Associates of Southwest Virginia
-
-
Washington
-
Vancouver, Washington, Forenede Stater, 98684
- Northwest Cancer Specialists, P.C.
-
-
-
-
-
Brest, Frankrig, 29200
- CHU Brest Hopital Cavale Blanche
-
Clermont-Ferrand, Frankrig, 63100
- CHU Estaing
-
Créteil, Frankrig, 94000
- Hopital Henri Mondor
-
Dijon, Frankrig, 21079
- Center Georges-Francois Leclerc
-
Lyon, Frankrig, 69437
- Hopital Edouard Herriot
-
Marseille, Frankrig, 13285
- Höpital Saint-Joseph
-
Nice, Frankrig, 06189
- Centre Antoine Lacassagne
-
Paris, Frankrig, 75012
- Hopital Saint-Antoine
-
Paris, Frankrig, 75015
- Hopital Europeen Georges Pompidou
-
Poitiers, Frankrig, 86000
- CHU Poitiers
-
Rouen, Frankrig, 76031
- CHU de Rouen
-
Saint-Herblain, Frankrig, 44805 Cedex
- Institut de Cancérologie de l'Ouest - Saint-Herblain
-
Saint-Priest-en-Jarez, Frankrig, 42270
- Centre Hospitalier Universitaire Sainte-Etienne - Hopital Nord
-
Strasbourg, Frankrig, 67033
- Institut de Cancerologie Strasbourg Europe
-
Toulouse, Frankrig, 31059
- CHU Toulouse-Rangueil
-
-
Other
-
Besançon, Other, Frankrig, 25000
- Centre Hospitalier Regional et Universitaire de Besancon - Hopital Jean-Minjoz
-
-
-
-
-
Athens, Grækenland, 11528
- Evgenidion Clinic Agia Trias Oncology Department
-
-
Attikí
-
Athens, Attikí, Grækenland, 11525
- Athens Medical Center - Psychikon branch
-
-
Chaidari
-
Athens, Chaidari, Grækenland, 124 62
- University General Hospital "Attikon"
-
-
Thessaloniki
-
Nea Efkarpia, Thessaloniki, Grækenland, 56403
- "Papageorgiou" General Hospital of Thessaloniki 2nd Internal Medicine/Oncology Clinic of Aristotle
-
-
-
-
-
Amsterdam, Holland, 1066 CX
- Netherlands Cancer Institute
-
Utrecht, Holland, 3543 AZ
- St. Antonius Ziekenhuis - Ziekenhuis Utrecht
-
Venlo, Holland, 5912 BL
- Viecuri Medisch Centrum
-
-
-
-
-
Cork, Irland, T12 DV56
- Bon Secours Hospital
-
Cork, Irland, T12 DC4A
- Cork University Hospital,Department of Medical Onncology
-
Dublin, Irland, D07 R2WY
- Mater Misericordiae University Hospital
-
Dublin, Irland, D07 WKW8
- Mater Private Hospital
-
Dublin, Irland, D09 V2N0
- Beaumont Hospital
-
Dublin, Irland, D04 T6F4
- St Vincents University Hospital
-
Waterford, Irland, X91 ER8E
- University Hospital Waterford
-
-
-
-
-
Foggia, Italien, 71122
- Struttura Semplice Dipartimentale di Oncologia Medica e Terapia Biomolecolare Azienda Ospedaliero
-
Pavia, Italien, 27100
- Fondazione IRCCS Policlinico San Matteo
-
Reggio Emilia, Italien, 42123
- S.C Oncologia Arcispedale Santa Maria Nuova
-
Sondrio, Italien, 23100
- ASST della Valtellina e dell'alto Lario - Presidio Ospedaliero di Sondrio
-
-
Cagliari
-
Monserrato, Cagliari, Italien, 09042
- Azienda Ospedaliera Universitaria Cagliari
-
-
Campania
-
Avellino, Campania, Italien, 83100
- UOC Oncologia Medica - Dipartimento Onco Ematologico AORN San Giuseppe Moscati di Avellino
-
-
Genoa
-
Genova, Genoa, Italien, 16132
- IRCCS Azienda Ospedaliera Metropolitana (IRCCS AOM)
-
-
Lazio
-
Rome, Lazio, Italien, 00168
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
-
-
Lecce
-
Tricase, Lecce, Italien, 73039
- UOC Oncologia, Azienda Ospedaliera Cardinale Giovanni Panico
-
-
Lombardy
-
Brescia, Lombardy, Italien, 25124
- Fondazione Poliambulanza Istituto Ospedaliero
-
Milan, Lombardy, Italien, 20133
- Fondazione IRCCS Istituto Nazionale dei Tumori
-
Milan, Lombardy, Italien, 20141
- lstituto Europeo di Oncologia
-
Milan, Lombardy, Italien, 20162
- Niguarda Cancer Center Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
-
-
Naples
-
Naples, Naples, Italien, 80131
- Azienda Ospedaliera Universitaria Luigi Vanvitelli
-
-
Tuscany
-
Florence, Tuscany, Italien, 50134
- SODc Oncologia Medica e Clinica, AOU Careggi
-
Pisa, Tuscany, Italien, 56126
- Azienda Ospedaliero Universitaria Pisana
-
-
Veneto
-
Padova, Veneto, Italien, 35128
- Istituto Oncologico Veneto - IRCCS
-
-
-
-
-
Osaka, Japan, 540-0006
- National Hospital Organization Osaka National Hospital
-
-
Chiba
-
Chiba, Chiba, Japan, 260-8717
- Chiba Cancer Center
-
Kashiwa-shi, Chiba, Japan, 277-8577
- National Cancer Center Hospital East
-
-
Ehime
-
Matsuyama, Ehime, Japan, 791-0280
- NHO Shikoku Cancer Center
-
-
Fukuoka
-
Fukuoka, Fukuoka, Japan, 811-1395
- National Hospital Organization Kyushu Cancer Center
-
-
Hokkaido
-
Sapporo, Hokkaido, Japan, 060-8648
- Hokkaido University Hospital
-
-
Kagawa-ken
-
Kita-gun, Kagawa-ken, Japan, 761-0793
- Kagawa University Hospital
-
-
Kanagawa
-
Kawasaki-shi, Kanagawa, Japan, 216-8511
- St. Marianna University Hospital
-
Yokohama, Kanagawa, Japan, 241-8515
- Kanagawa Cancer Center
-
-
Osaka
-
Osaka, Osaka, Japan, 558-8558
- Osaka General Medical Center
-
Osakasayama-shi, Osaka, Japan, 589-8511
- Kindai University Hospital
-
Sakai, Osaka, Japan, 590-0197
- Kindai University Hospital
-
Suita, Osaka, Japan, 565-0871
- The University of Osaka Hospital
-
Takatsuki-shi, Osaka, Japan, 569-8686
- Osaka Medical and Pharmaceutical University Hospital
-
-
Saitama
-
Kitaadachi-gun, Saitama, Japan, 362-0806
- Saitama Cancer Center
-
-
Tokyo
-
Chuo-Ku, Tokyo, Japan, 104-0045
- National Cancer Center Hospital
-
Koto-ku, Tokyo, Japan, 135-8550
- Cancer Institute Hospital of JFCR
-
-
-
-
-
Beijing, Kina, 100142
- Beijing Cancer Hospital
-
Changsha, Kina, 410013
- Hunan Cancer Hospital
-
Chongqing, Kina, 400042
- Army Specialty Medical Center of The Chinese People's Liberation Army
-
Shanghai, Kina, 201620
- Shanghai General Hospital
-
-
Fujian
-
Fuzhou, Fujian, Kina, 350001
- Fujian Medical University Union Hospital
-
-
Gansu
-
Lanzhou, Gansu, Kina, 730000
- The First Hospital of Lanzhou University
-
-
Guangdong
-
Guangzhou, Guangdong, Kina, 510655
- The Sixth Affiliated hospital, Sun Yat-sen University
-
Meizhou, Guangdong, Kina, 514031
- Meizhou People's hospital
-
-
Hainan
-
Haikou, Hainan, Kina, 570216
- The Second Affiliated Hospital of Hainan Medical University
-
-
Hebei
-
Chengde, Hebei, Kina, 067000
- Affiliated Hospital of Chengde Medical University
-
Chengde, Hebei, Kina, 067055
- Affiliated Hospital of Chengde Medical University
-
Tangshan, Hebei, Kina, 063001
- Tangshan People's Hospital
-
-
Heilongjiang
-
Harbin, Heilongjiang, Kina, 150081
- Harbin Medical University Cancer Hospital
-
-
Henan
-
Nanyang, Henan, Kina, 473009
- Nanyang Second General Hospital
-
Zhengzhou, Henan, Kina, 450003
- Henan Provincial People's Hospital
-
-
Hubei
-
Wuhan, Hubei, Kina, 430079
- Hubei Cancer Hospital
-
-
Hunan
-
Changsha, Hunan, Kina, 410011
- The Second Xiangya Hospital of Central South University
-
-
Jiangsu
-
Changzhou, Jiangsu, Kina, 213003
- The First People's Hospital of Changzhou
-
Suzhou, Jiangsu, Kina, 215031
- The First Affiliated Hospital of Suzhou University
-
Xuzhou, Jiangsu, Kina, 221009
- Xuzhou Central Hospital
-
-
Jiangxi
-
Nanchang, Jiangxi, Kina, 330006
- The First Affiliated Hospital of Nanchang University
-
-
Liaoning
-
Jinzhou, Liaoning, Kina, 121001
- The First Affiliated Hospital of Jinzhou Medical University
-
Shenyang, Liaoning, Kina, 110042
- Liaoning Cancer Hospital & Institute
-
-
Shandong
-
Jinan, Shandong, Kina, 250013
- Jinan Central Hospital
-
Jinan, Shandong, Kina, 250117
- Shandong Cancer Hospital
-
Linyi, Shandong, Kina, 276034
- LinYi Cancer Hospital
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina, 200092
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
-
-
Shanxi
-
Taiyuan, Shanxi, Kina, 030013
- Shanxi Province Cancer Hospital
-
-
Zhejiang
-
Hangzhou, Zhejiang, Kina, 310009
- The Second Affiliated Hospital of Zhejiang University School of Medicine
-
Hangzhou, Zhejiang, Kina, 310016
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
-
-
-
-
-
Oslo, Norge, 0379
- Oslo University Hospital (OUH) - The Norwegian Radium Hospital
-
-
-
-
-
Lodz, Polen, 91-211
- Salve Medica
-
-
Greater Poland Voivodeship
-
Konin, Greater Poland Voivodeship, Polen, 62-500
- Przychodnia Lekarska KOMED Roman Karaszewski
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polen, 02-034
- Narodowy lnstytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy lnstytut Badawczy
-
-
Pomeranian Voivodeship
-
Gdansk, Pomeranian Voivodeship, Polen, 80-214
- Klinika Onkologii i Radioterapii Uniwersyteckie Centrum Kliniczne.
-
-
-
-
-
Almada, Portugal, 2805-267
- Hospital Garcia de Orta
-
Guarda, Portugal, 6300-035
- Unidade Local de Saude da Guarda-Hospital Sousa Martins
-
Lisbon, Portugal, 1400-038
- Fundacao Champalimaud
-
Porto, Portugal, 4099-001
- Centro Hospitalar Universitário de Santo Antonio,E.P.E.
-
-
-
-
-
Zurich, Schweiz, 8091
- Universitatsspital Zurich - Klinik fur Medizinische Onkologie und Hamatologie USZ
-
-
-
-
-
Bratislava, Slovakiet, 833 10
- Narodny Onkologicky ustav II.Onkologicka Klinika LFUK a NOU
-
-
-
-
-
Alicante, Spanien, 03010
- Hospital General Universitario de Alicante
-
Barcelona, Spanien, 08036
- Hospital Clinic de Barcelona
-
Barcelona, Spanien, 08035
- Hospital Vall d'Hebron
-
Barcelona, Spanien, 08029
- Radiology: CETIR Ascires
-
Córdoba, Spanien, 14004
- Hospital Universitario Reina Sofia
-
Lleida, Spanien, 25198
- Hospital Universitari Arnau de Vilanova
-
Madrid, Spanien, 28034
- Hospital Universitario Ramon y Cajal
-
Madrid, Spanien, 28041
- Hospital Universitario 12 de Octubre
-
Madrid, Spanien, 28046
- Hospital Universitario La Paz
-
Madrid, Spanien, 28007
- Hospital General Universitario Gregorio Maranon
-
Málaga, Spanien, 29011
- Hospital Regional Universitario de Malaga (Hospital Civil)
-
Ourense, Spanien, 32005,
- Complejo Hospitalario Universitario de Ourense
-
Oviedo, Spanien, 33011
- Hospital Universitario Central de Asturias
-
Pamplona, Spanien, 31008
- Complejo Hospitalario de Navarra
-
Santander, Spanien, 39008
- Hospital Universitario Marques de Valdecilla
-
Seville, Spanien, 41013
- Hospital Universitario Virgen del Rocio
-
Valencia, Spanien, 46014
- Hospital General Universitario de Valencia
-
Zaragoza, Spanien, 50009
- Hospital Universitario Miguel Servet
-
Zaragoza, Spanien, 50006
- Hospital Quiron Salud Zaragoza
-
-
Barcelona
-
L'Hospitalet de Llobregat, Barcelona, Spanien, 08908
- Hospital Duran i Reynals - Institut Catala d'Oncologia L'Hospitalet (ICO L'Hospitalet)
-
-
Other
-
Barcelona, Other, Spanien, 08029
- CETIR Viladomat
-
-
Santa CRUZ DE Tenerife
-
San Cristóbal de La Laguna, Santa CRUZ DE Tenerife, Spanien, 38320
- Complejo Hospitalario Universitario de Canarias
-
-
-
-
-
Incheon, Sydkorea, 21565
- Gachon University Gil Medical Center
-
Seoul, Sydkorea, 03080
- Seoul National University Hospital
-
Seoul, Sydkorea, 05505
- Asan Medical Center
-
Seoul, Sydkorea, 06351
- Samsung Medical Center
-
Seoul, Sydkorea, 03722
- Severance Hospital, Yonsei University Health System
-
Seoul, Sydkorea, 02841
- Korea University Anam Hospital
-
Seoul, Sydkorea, 08308
- Korea University Guro Hospital
-
-
-
-
-
Kaohsiung City, Taiwan, 833, (R.O.C.)
- Kaohsiung Chang Gung Memorial Hospital
-
Tainan, Taiwan, 704, R.O.C.
- National Cheng Kung University Hospital
-
Taipei, Taiwan, 11217
- Taipei Veterans General Hospital
-
Taipei, Taiwan, 100 ROC
- National Taiwan University Hospital
-
Taoyuan, Taiwan, 333 (R.O.C.)
- Chang Gung Memorial Hospital LinKou
-
-
-
-
-
Berlin, Tyskland, 13353
- Charité - Universitätsmedizin Berlin
-
Chemnitz, Tyskland, 09116
- Klinikum Chemnitz gGmbH
-
Dresden, Tyskland, 01307
- Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus
-
Dresden, Tyskland, 01307
- Gemeinschaftspraxis Hämatologie - Onkologie
-
Hamburg, Tyskland, 22297
- Hämatologisch Onkologische Praxis Eppendorf (HOPE)
-
Hamburg, Tyskland, 22763
- Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona
-
Hanover, Tyskland, 30625
- Medizinische Hochschule Hannover (MHH)
-
Ulm, Tyskland, 89081
- Universitaetsklinikum Ulm
-
-
Bavaria
-
Munich, Bavaria, Tyskland, D-81675
- CCC Muenchen TUM
-
-
Saxony
-
Leipzig, Saxony, Tyskland, 04103
- Universitätsklinikum Leipzig
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Histologically and/or cytologically confirmed adenocarcinoma of the colon or rectum which is locally advanced unresectable or metastatic
-
Able to provide the most recently available formalin-fixed paraffin-embedded (FFPE) tumor tissue blocks (or freshly sectioned slides) obtained prior to treatment initiation to a central laboratory
- If archival tissue is not available, a newly-obtained baseline biopsy of an accessible tumor lesion is required within 35 days prior to start of study treatment
-
HER2+ disease as determined by a tissue based assay performed at a central laboratory.
-
Participant has rat sarcoma viral oncogene homolog wild-type (RAS WT) disease as determined by local or central testing. For central RAS analysis, tissue sample must be analyzed within 1 year of biopsy date.
-
Radiographically measurable disease per RECIST v1.1 with:
- At least one site of disease that is measurable and that has not been previously irradiated, or
- If the participant has had previous radiation to the target lesion(s), there must be evidence of progression since the radiation
-
Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1
-
CNS Inclusion - based on contrast brain magnetic resonance imaging, participants may have any of the following:
- No evidence of brain metastases
- Previously treated brain metastases which are asymptomatic
Exclusion Criteria:
-
Prior systemic anticancer therapy for colorectal cancer (CRC) in the locally advanced unresectable or metastatic setting; note that participants may have received a maximum of 2 doses of mFOLFOX6 in the locally advanced/unresectable or metastatic setting prior to randomization.
- Note: May have received chemotherapy for CRC in the adjuvant setting if it was completed >6 months prior to enrollment
-
Radiation therapy within 14 days prior to enrollment (or within 7 days in the setting of stereotactic radiosurgery)
-
Previous treatment with anti-HER2 therapy
-
Ongoing Grade 3 or higher neuropathy
-
Active or untreated gastrointestinal (GI) perforation at the time of screening.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Tucatinib Arm
Tucatinib + trastuzumab + mFOLFOX6 |
300mg given by mouth (orally) twice daily
Andre navne:
8mg/kg loading dose will be given into the vein (IV; intravenously) on Cycle 1 day 1, followed by 6mg/kg given by IV every 3 weeks thereafter.
Andre navne:
85mg/m2 given by IV every 2 weeks. Component of mFOLFOX6. 400mg/ m2 given by IV every 2 weeks. Component of mFOLFOX6. 200mg/ m2 given by IV every 2 weeks. May be given in place of leucovorin. Component of mFOLFOX6. 400mg/m2 given by IV bolus then 2400mg/m2 given by continuous IV infusion (over 46-48 hours) every 2 weeks. Component of mFOLFOX6. |
|
Aktiv komparator: Standard of Care Arm
Either (1) mFOLFOX6, (2) mFOLFOX6 and bevacizumab, or (3) mFOLFOX6 and cetuximab |
85mg/m2 given by IV every 2 weeks. Component of mFOLFOX6. 400mg/ m2 given by IV every 2 weeks. Component of mFOLFOX6. 200mg/ m2 given by IV every 2 weeks. May be given in place of leucovorin. Component of mFOLFOX6. 400mg/m2 given by IV bolus then 2400mg/m2 given by continuous IV infusion (over 46-48 hours) every 2 weeks. Component of mFOLFOX6. 5mg/kg given by IV every 2 weeks
Andre navne:
400mg/m2 loading dose will be given by IV on Cycle 1 day 1, followed by 250mg/m2 given by IV weekly
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) by Blinded Independent Central Review (BICR)
Tidsramme: Up to approximately 3 years
|
The time from the date of randomization to the BICR assessment of disease progression according to RECIST v1.1 or death from any cause |
Up to approximately 3 years
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Forekomst af dosisændringer
Tidsramme: Gennem 30 dage efter den sidste undersøgelsesbehandling; cirka 1 år
|
Gennem 30 dage efter den sidste undersøgelsesbehandling; cirka 1 år
|
|
|
Overall survival (OS)
Tidsramme: Up to approximately 6 years
|
The time from randomization to death from any cause |
Up to approximately 6 years
|
|
Confirmed objective response rate (cORR) per RECIST v1.1 by BICR
Tidsramme: Up to approximately 3 years
|
The proportion of participants with confirmed complete response (CR) or partial response (PR) according to RECIST v1.1, as assessed by BICR |
Up to approximately 3 years
|
|
PFS per RECIST v1.1 by investigator assessment
Tidsramme: Up to approximately 3 years
|
The time from the date of randomization to the investigator assessment of disease progression according to RECIST v1.1 or death from any cause |
Up to approximately 3 years
|
|
cORR per RECIST v1.1 by investigator assessment
Tidsramme: Up to approximately 3 years
|
The proportion of participants with confirmed CR or PR according to RECIST v1.1, as assessed by investigators |
Up to approximately 3 years
|
|
Duration of response (DOR) per RECIST v1.1 by BICR
Tidsramme: Up to approximately 3 years
|
The time from first documentation of objective response (CR or PR that is subsequently confirmed) to the first documentation of disease progression per RECIST v1.1 or death from any cause |
Up to approximately 3 years
|
|
DOR per RECIST v1.1 by investigator assessment
Tidsramme: Up to approximately 3 years
|
The time from first documentation of objective response (CR or PR that is subsequently confirmed) to the first documentation of disease progression per RECIST v1.1 or death from any cause |
Up to approximately 3 years
|
|
Time to second progression or death (PFS2)
Tidsramme: Up to approximately 3 years
|
The time from randomization to disease progression on the next-line of therapy, or death from any cause |
Up to approximately 3 years
|
|
Incidence of adverse events (AEs)
Tidsramme: Through 30 days after the last study treatment; approximately 1 year
|
Any untoward medical occurrence in a clinical investigational participant administered a medicinal product and which does not necessarily have a causal relationship with this treatment. |
Through 30 days after the last study treatment; approximately 1 year
|
|
Trough concentration (Ctrough)
Tidsramme: Approximately 4 months
|
PK parameter |
Approximately 4 months
|
|
Change from baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQC30) score
Tidsramme: Through 30-37 days after the last study treatment; approximately 1 year
|
Change from baseline in European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) scores. Scale scores range from 0-100. For functioning and global health status/quality of life (QoL) scales, higher scores indicate better functioning or global health status/quality of life (QoL). For symptom scales, higher scores indicate greater symptom burden. |
Through 30-37 days after the last study treatment; approximately 1 year
|
|
Time to meaningful change in EORTC QLQ30 score
Tidsramme: Through 30-37 days after the last study treatment; approximately 1 year
|
The time from baseline to the first onset of a ≥10-point changes in European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) scores. Scale scores range from 0-100. For functioning and global health status/QoL scales, higher scores indicate better functioning or global health status/QoL. For symptom scales, higher scores indicate greater symptom burden. |
Through 30-37 days after the last study treatment; approximately 1 year
|
Samarbejdspartnere og efterforskere
Efterforskere
- Studieleder: Pfizer CT.gov Call Center, Pfizer
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Neoplasmer efter sted
- Neoplasmer
- Tarmsygdomme
- Gastrointestinale neoplasmer
- Neoplasmer i fordøjelsessystemet
- Sygdomme i fordøjelsessystemet
- Gastrointestinale sygdomme
- Intestinale neoplasmer
- Endetarmssygdomme
- Tyktarmssygdomme
- Kolorektale neoplasmer
- Aminosyrer, peptider og proteiner
- Proteiner
- Organiske kemikalier
- Heterocykliske forbindelser, 1-ring
- Heterocykliske forbindelser
- Heterocykliske forbindelser, 2-ring
- Heterocykliske forbindelser, smeltet ring
- Enzymer og coenzymer
- Antistoffer, monoklonal, humaniseret
- Antistoffer, monoklonal
- Antistoffer
- Immunoglobuliner
- Immunoproteiner
- Blodproteiner
- Serum globuliner
- Globuliner
- Koordinationskomplekser
- Pyrimidiner
- Formyltetrahydrofolater
- Tetrahydrofolater
- Folinsyre
- Pterins
- Pteridiner
- Uracil
- Pyrimidinoner
- Coenzymer
- Trastuzumab
- Oxaliplatin
- Bevacizumab
- Cetuximab
- Fluorouracil
- Leucovorin
- Levoleucovorin
- Tucatinib
Andre undersøgelses-id-numre
- SGNTUC-029
- C4251008 (Anden identifikator: Alias Study Number)
- 2024-514180-25-00 (Registry Identifier: CTIS (EU))
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .